SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is experiencing significant market volatility after its latest earnings report and a cautious Q1 outlook, fueling a sharp debate among investors. Many in the community are calling the substantial price drop an overreaction, pointing to temporary supply constraints and future foundry growth as buying opportunities. Conversely, a strong bearish sentiment suggests the decline is a justified correction, citing ongoing competitive challenges and valuation concerns within the semiconductor sector.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is trending, fueled by its pemvidutide receiving Breakthrough Therapy Designation for MASH, igniting robust speculation about potential acquisitions or partnerships within the competitive GLP-1 and liver disease sector. The community is actively debating the stock's future, with many anticipating a significant rerating amidst increased trading volume, while a vocal segment raises concerns about previous rumors and ongoing legal scrutiny regarding trial data integrity.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending following reports of its finalized deal to establish a U.S. joint venture with TikTok, positioning Oracle to manage U.S. user data and take an equity stake. This development is driving significant community discussion, with many anticipating a substantial upside from Oracle's expanded role in a major consumer platform and its long-term cloud and AI infrastructure growth, while others express caution given the stock's recent volatility and existing debt concerns.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust ($SLV) is experiencing a massive surge as the community passionately anticipates reaching the $100 mark, driven by intense short squeeze narratives and mounting concerns over physical silver shortages. Bulls are largely dismissing calls for a pullback, highlighting strong industrial demand from sectors like solar and EVs, coupled with broader de-dollarization trends and inflation fears, as key catalysts.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending due to recent news of its partnership with Fluor and WSP to advance the Round Top rare earth project, complemented by significant financial backing from the French government for a new European metals and alloys production facility. The community is actively discussing the company's strengthening position in establishing an integrated, non-Chinese rare earth supply chain, fueled by broader geopolitical demand for critical minerals.

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ Corp. is driving intense investor conversation due to its recent Memorandum of Understanding with the Indian government to establish a substantial post-quantum semiconductor center and prominent discussions on quantum security at the Davos World Economic Forum. The community is highly focused on the company's strategic position in securing critical infrastructure against future quantum threats, particularly for AI and IoT systems. This narrative, combined with high short interest, is fueling expectations for significant shifts in its valuation.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire is trending with remarkable trading volume, driven by its strategic unification of space and defense businesses alongside community anticipation of new contracts. The market is actively discussing the company's cutting-edge technology, strong institutional buying absorbing recent share sales, and notable short interest, positioning RDW as a potential breakout in the expanding 'Space 2.0' and defense sectors.

Ascent Solar Technologies, Inc. engages in the design, development, and manufacture of solar technology and power solutions for remote locations and extreme environments. It integrates photovoltaic modules into a variety of applications such as aerospace, defense, transportation, and electronic products. The company was founded by Mohan S. Misra and Joseph H. Armstrong on October 18, 2005 and is headquartered in Thornton, CO.

Ascent Solar Technologies Inc

Ascent Solar Technologies (ASTI) is trending amid surging interest in its flexible, featherweight thin-film solar technology, directly aligning with recent high-profile discussions about solar-powered AI data centers in space. The community is actively debating the stock's potential, fueled by news of strategic partnerships, a recent private placement, and confirmed involvement in major space constellation projects, leading to significant short-squeeze speculation given its low float.

Movano, Inc. is a health-focused technology company. The firm uses non-invasive technology to enable individuals and their healthcare partners to measure and manage their health conditions. It offers solutions through the app, the cloud, the wearable, and the sensor. The company was founded by Michael Aaron Leabman in January 2018 and is headquartered in Pleasanton, CA.

Movano Inc

Movano (MOVE) is experiencing significant market interest driven by its merger partner, Corvex, securing a long-term NVIDIA H200 GPU deployment with an AI-driven battery technology provider. The stock's extremely low float is a major talking point, with community members anticipating further volatility and potential upward movement, while others caution about past dilution and a history of sharp pullbacks.

BitGo Holdings, Inc. provides cryptocurrency custody solutions. It offers self-custody wallet, qualified custody, liquidity and prime, and infrastructure-as-a-service. The company was founded by Michael Belshe in 2013 and is headquartered in Palo Alto, CA.

BitGo Holdings Inc. - Ordinary Shares - Class A

BitGo Holdings Inc. (BTGO) is trending following its recent IPO, opening above its initial price range as the first crypto custodian to list publicly. Community discussions are highly polarized, with many anticipating significant upside due to its low share float and crucial role in facilitating institutional crypto inflows, while others express caution over initial price volatility and comparisons to prior digital asset IPOs. Investors are actively debating its potential for a substantial run versus concerns about a rapid downturn.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider

Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $467.35, signifying a +1.35% move from its prior day's close.

Biotech Stocks To Keep An Eye On - January 22nd

Moderna, Brainstorm Cell Therapeutics, ImmunityBio, Danaher, Vertex Pharmaceuticals, argenex, and Recursion Pharmaceuticals are the seven Biotech stocks to watch today, according to MarketBeat's...

Vertex Pharmaceuticals (NASDAQ:VRTX) Upgraded to Outperform at Royal Bank Of Canada

Royal Bank Of Canada upgraded shares of Vertex Pharmaceuticals from a "sector perform" rating to an "outperform" rating and set a $546.00 price target on the stock in a research report on Thursday...

Boston Common Asset Management LLC Sells 5,164 Shares of Vertex Pharmaceuticals Incorporated $VRTX

Boston Common Asset Management LLC trimmed its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 11.2% in the 3rd quarter, according to its most recent filing with the...

Why Is Vertex Pharmaceuticals (VRTX) Stock Trending Overnight?

Vertex Pharmaceuticals shares dipped slightly in after-hours trading following Wednesday's session.read more...

Promising Biotech Stocks To Consider - January 21st

Moderna, ImmunityBio, Danaher, Vertex Pharmaceuticals, argenex, BioNTech, and Legend Biotech are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks...

Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC trimmed its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 11.1% in the third quarter, according to the company in its most...

Rakuten Investment Management Inc. Makes New $94.96 Million Investment in Vertex Pharmaceuticals Incorporated $VRTX

Rakuten Investment Management Inc. bought a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the third quarter, according to the company in its most recent...

Vertex Pharmaceuticals Incorporated $VRTX Stake Boosted by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH boosted its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 1.8% during the third quarter, according to its most...

Migdal Insurance & Financial Holdings Ltd. Makes New Investment in Vertex Pharmaceuticals Incorporated $VRTX

Migdal Insurance & Financial Holdings Ltd. acquired a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 3rd quarter, according to the company in its...

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Vertex Pharmaceuticals, Inc.

Policy uncertainty from Trump

Earnings & guidance

Options / dealer positioning

Liquidity & algos

Markets are reacting to a mix of policy headlines, earnings, and positioning. We want to hear what you think is driving volatility the most right now.

What&#39;s the biggest driver of market volatility right now?

Stocktwits

What's the biggest driver of market volatility right now?

VRTX
Vertex Pharmaceuticals, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest VRTX News

VRTXVertex Pharmaceuticals, Inc.